Tomaschitz, A., März, W., & Ritz, E. (2016). Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: Results from the Epath randomized, placebo-controlled trial. Journal of hypertension, 34(7), . https://doi.org/10.1097/HJH.0000000000000927
Chicago Style (17th ed.) CitationTomaschitz, Andreas, Winfried März, and Eberhard Ritz. "Effect of Eplerenone on Parathyroid Hormone Levels in Patients with Primary Hyperparathyroidism: Results from the Epath Randomized, Placebo-controlled Trial." Journal of Hypertension 34, no. 7 (2016). https://doi.org/10.1097/HJH.0000000000000927.
MLA (9th ed.) CitationTomaschitz, Andreas, et al. "Effect of Eplerenone on Parathyroid Hormone Levels in Patients with Primary Hyperparathyroidism: Results from the Epath Randomized, Placebo-controlled Trial." Journal of Hypertension, vol. 34, no. 7, 2016, https://doi.org/10.1097/HJH.0000000000000927.